Novel Myofilament Ca2+-Sensitizing Property of Xanthine Oxidase Inhibitors

Circulation Research - United States
doi 10.1161/01.res.83.4.423
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)